# Quality Assurance Report

## Identity

| Field | Value |
|---|---|
| QA Report ID | QA-PP-0175 |
| PP ID | PP-0175 |
| Title | Gastric Cancer Diagnostic Work-up |
| Version | 1.0.0 |
| Status | PASS — GOLD |

# Layer 1 — Content QA

| Criterion | Result |
|---|---|
| Atomic clinical question | PASS |
| Approved PP identity | PASS |
| Full-depth CKO structure | PASS |
| Full-depth Knowledge Passport | PASS |
| Full-depth Evidence Package | PASS |
| Granular knowledge blocks | PASS |
| Patient Explanation per block | PASS |
| Clinical Importance per block | PASS |
| Key Concepts per block | PASS |
| Common Misconceptions | PASS |
| Key Messages | PASS |
| Knowledge Graph | PASS |
| Revision History | PASS |
| Scope / Included | PASS |
| Explicit exclusions | PASS |

# Layer 2 — Clinical QA

| Criterion | Result |
|---|---|
| Source-first clinical grounding | PASS |
| NCCN v2.2026 represented | PASS |
| Vietnam MOH guideline represented | PASS |
| ACS patient-facing evidence represented | PASS |
| Suspicion distinguished from diagnosis | PASS |
| Diagnosis distinguished from staging | PASS |
| Endoscopy role correctly bounded | PASS |
| Biopsy/pathology role correctly bounded | PASS |
| CT role correctly bounded | PASS |
| PET/CT described as selective | PASS |
| EUS described as selected local-staging tool | PASS |
| Laparoscopy described as selective | PASS |
| Early gastric cancer complexity preserved | PASS |
| Biomarker interface preserved without absorbing biomarker PPs | PASS |
| No universal diagnostic sequence invented | PASS |
| No individualized diagnosis | PASS |
| No treatment recommendation | PASS |
| Evidence gaps explicit | PASS |

# Layer 3 — Educational QA

| Criterion | Result |
|---|---|
| Patient-centered framing | PASS |
| Plain-language explanation | PASS |
| Medical terminology explained | PASS |
| Granular one-concept knowledge blocks | PASS |
| Diagnostic pathway logically sequenced | PASS |
| Risk of overinterpretation addressed | PASS |
| Misconceptions addressed | PASS |
| Uncertainty visible | PASS |
| No alarmist language | PASS |
| No individualized medical instruction | PASS |
| Clear explanation of why multiple tests may be needed | PASS |

# Layer 4 — Governance QA

| Criterion | Result |
|---|---|
| CORE_WORKING_RULES v1.6 | PASS |
| Source-First rule | PASS |
| User-controlled PP sequence | PASS |
| Approved Decision Batch basis | PASS |
| Gold Discussion depth principle | PASS |
| Gold artifact structure | PASS |
| Full-depth / non-compacted production | PASS |
| Adjacent PP overlap check | PASS |
| Boundary ownership | PASS |
| Knowledge Graph | PASS |
| Evidence traceability | PASS |
| Four artifacts complete | PASS |
| Single ZIP package | PASS |
| Semantic versioning | PASS |
| Repository-ready structure | PASS |

# Full-Depth Compliance Check

This PP was produced under the project's absolute full-depth rule.

The CKO contains a granular 25-block clinical knowledge architecture, with each block separated into:

1. Patient Explanation;
2. Clinical Importance;
3. Key Concepts.

The Knowledge Passport independently covers:

- Identity;
- Knowledge Classification;
- Patient Journey Classification;
- Intended Runtime Usage;
- Retrieval / Runtime Relevance;
- Knowledge Graph;
- Clinical Scope;
- Authoritative Sources;
- Evidence Classification;
- Governance Metadata;
- Version Control;
- Change History;
- Final Status.

The Primary Evidence Package independently covers:

- Identity;
- Clinical Question;
- Educational Intent;
- Scope;
- Included;
- Excluded;
- Primary Sources;
- Supporting Sources;
- Evidence Hierarchy;
- Evidence Matrix;
- Evidence Notes;
- Clinical Claims Summary;
- Evidence Consistency Review;
- Evidence Gaps;
- Out-of-Scope Topics;
- Future Update Triggers;
- Source Traceability;
- Boundary Verification;
- Evidence Package Decision;
- Final Evidence Status.

The QA Report independently evaluates all four QA layers and includes a dedicated full-depth compliance check.

**The package is explicitly non-compacted.**

# Boundary QA

**Boundary: Core = the integrated gastric-cancer diagnostic work-up from clinical suspicion through diagnostic confirmation, disease characterization and initial staging assessment, including clinical assessment, upper endoscopy as the diagnostic entry point, tissue confirmation, cross-sectional imaging, selected EUS/PET-CT/laparoscopy, Siewert/location assessment, and the interface with pathology and clinically relevant biomarker testing; Supporting = laboratory/organ-function assessment, nutritional assessment, family-history and H. pylori context, multidisciplinary interpretation, and patient-facing explanation of why multiple tests may be needed; Explicitly Excluded = detailed endoscopic diagnosis, detailed biopsy technique, histopathologic classification, Lauren classification, molecular classification, biomarker-specific testing/interpretation, detailed CT/PET/EUS/laparoscopy methodology, full TNM/stage-group teaching, individualized diagnostic interpretation, and all treatment selection or treatment-management recommendations; Delegated-to PP = PP-0176 Endoscopic Diagnosis, PP-0177 Endoscopic Biopsy Strategy, PP-0178 Histopathologic Classification, PP-0179 Lauren Classification, PP-0180 Molecular Classification, PP-0181+ Biomarker Testing, dedicated staging/imaging packages, PP-0192–0194 Endoscopic Resection/EMR/ESD, and downstream Gastric Cancer Treatment packages.**

# Architecture QA

PP-0175 remains an integrated diagnostic-work-up package and does not absorb detailed ownership of:

- endoscopic diagnosis;
- biopsy strategy;
- pathology;
- Lauren classification;
- molecular classification;
- biomarker-specific testing;
- detailed imaging;
- detailed staging;
- endoscopic resection;
- treatment.

The package therefore acts as the diagnostic-work-up orchestration layer between screening/suspicion and specialized downstream diagnostic/staging packages.

# Final QA Decision

## PASS

All four Gold artifacts are complete, full-depth, source-grounded, clinically bounded, and aligned with the approved/locked PP-0175 Decision Batch.

# QA Final Status

**PASS — GOLD — READY FOR INTEGRATION.**
